mITCHELL s. cAIRO, md
Dr. Cairo is the Chief of the Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Director of the Adult & Pediatric BMT Program, Director of the Childhood and Adolescent Cancer and Blood Disease Center, Medical and Scientific Director of the GMP Cellular and Tissue Engineering Laboratory at Westchester Medical Center (WMC), Medical Director of the WMC Hematotherapy Program and Co-Chair of the WMC Cancer Committee.
Dr. Cairo has over 410 peer-reviewed publications and serves on the editorial boards of several scholarly journals. For the last 20 years, Dr. Cairo has been a leading researcher in the Children’s Oncology Group which leads the nation in Pediatric Clinical Research Trials. Dr. Cairo is an international leader in the biology and treatment of childhood lymphomas and leukemias, stem cell transplantation, developmental therapeutics, experimental hematopoiesis and
immunology, stem cell biology and regenerative therapy. He is a pioneer in the use of cord blood stem cells for treating malignant and non-malignant disease, for potential regenerative therapy and haploidentical stem cell transplantation for patients with sickle cell disease.
In summary, Dr. Cairo has been an international leader in basic, translational and clinical research in childhood, adolescent and young adults with an emphasis in stem cell transplantation, stem cell biology, lymphoma, tumor immunology, and developmental therapeutics.
Allyson Flower, MD
Allyson Flower, MD is a graduate of St George’s University School of Medicine. She completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at New York Medical College. Dr. Flower joined the faculty at New York Medical College in 2016 and is presently an Assistant Professor of Pediatrics within the division of Hematology, Oncology, and SCT and the division of Microbiology and Immunology. Clinical interests include Hematologic Malignancy, Hematopoietic Stem Cell Transplantation, and Adolescent and Young Adult Oncology. Translational research interests include Cellular Immunotherapy. Dr. Flower is the recipient of the 2017 Hyundai Hope on Wheels Young Investigator Award for ongoing research entitled “Overcoming Natural Killer (NK) Cell Resistance in Poor-Risk Neuroblastoma (NB).”
jessica hochberg, md
Dr. Hochberg joined the faculty of New York Medical College in 2009, and is presently an Assistant Professor of Clinical Pediatrics within the division of Pediatric Hematology, Oncology, and Stem Cell Transplantation. She specializes in hematologic malignancies, tumor lysis syndrome and late effects of cancer therapy. She is currently the Director of the Hematologic Malignancy Program, Director of the Wellness and Survivorship program and Associate Director of the Pediatric Hematology/Oncology Fellowship. She currently serves as the Institutional PI for the Children’s Oncology Group. Dr. Hochberg’s research interests involve development of novel therapeutics and targeted immunotherapy in order to improved outcomes and reduce the burden of traditional chemoradiotherapy in pediatric leukemia and lymphoma.
mehmet fevzi ozkaynak, md
Dr. Ozkaynak’s interest has been the treatment of neuroblastoma, a unique childhood cancer. He has been the Vice-Chair of a Children’s Oncology Group (COG) protocol which has established the role of immunotherapy in the treatment of advanced neuroblastoma. He then led the COG protocol for FDA Biologic License Application for immunotherapy in patients with advanced neuroblastoma, which has recently been successful. This has led to the establishment of a new standard in North America and around the globe for the treatment of advanced neuroblastoma. Dr. Ozkaynak continues his research activities in neuroblastoma and other childhood solid tumors by improving upon the above treatment protocol results while creating new ones including immune checkpoint inhibition.
jeremy rosenblum, md
Dr. Rosenblum joined the faculty of New York Medical College in 2014 as an Assistant Professor of Pediatrics. He specializes in the treatment of children with sarcomas and other solid tumors. Dr. Rosenblum is developing new therapeutic strategies to treat cancer that exploit new insights into cancer biology and the immune system. He is developing a program in personalized cancer medicine to treat cancers that have recurred despite treatment. He also studies the infectious complications of cancer therapy. His areas of interest include: sarcomas and personalized cancer medicine
claudio sandoval, md
Dr. Sandoval graduated from New York Medical College in 1987 and completed pediatric residency training at Schneider Children’s Hospital and pediatric hematology-oncology training at St. Jude Children’s Research Hospital. He has dedicated his entire career to caring for children with cancer and blood disorders at New York Medical College. His interests comprise sickle, cell disease, hemophilia and leukemia and mentoring college and medical students.
OYA LEVENDOGLU-TUGAL, MD
In addition to her vast experience and active involvement in the treatment of pediatric oncology patients, Dr. Tugal’s main focus in recent years is in pediatric bleeding disorders and thrombosis. She is conducting clinical research in the treatment of venous thrombosis in children with a novel oral anticoagulant. Histiocytic disorders in children Childhood cancers including leukemia, lymphoma, neuroblastoma, solid tumors, brain tumors, histiocytic disorders, platelet disorders, hemoglobinopathies, bleeding, and thrombosis. is one of her strong interests.
lila pereira, phd
Dr. Pereira, is a Postdoctoral Pediatric Psychology Fellow in Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York Medical College and Maria Fareri Children's Hospital. She completed an APA-accredited internship at Child Clinical and Pediatric Psychology at Metrohealth Center in Cleveland, Ohio. She earned an M.A. at The New School in psychology before earning a Ph.D. at the APA-Accredited Pacific Graduate School of Psychology at Palo Alto University. Dr. Pereira conducted her doctoral research on the process and benefits of making video testimonials in adolescents with cancer. Her current research focuses on the expansion of this research in AYA survivors of cancer and family members of young people diagnosed with cancer; as well as projects involving outcomes of Adolescent and Young Adult Cancer Patients and other peer support programs for patients and families by pediatric cancer and blood disorders.